View of Complete response to pembrolizumab as a single agent in a patient with stage III NSCLC with high PD-L1 expression: a case report

Return to Article Details Complete response to pembrolizumab as a single agent in a patient with stage III NSCLC with high PD-L1 expression: a case report Download Download PDF